Close Menu

NEW YORK – Chinese precision oncology company Genetron Health said Wednesday that it is collaborating with Darui Biotechnology to support Darui's development of pathogenic microorganism detection products on its sequencer.

The detection kits will run on the Genetron S5 next-generation sequencer. Genetron will also help Darui apply for registration of its reagent kits with regulatory authorities, the company said. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Aug
18

As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.